Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 1619
116th Congress(2019-2020)
VACCINES Act
Introduced
Introduced
Introduced in Senate on May 22, 2019
Overview
Text
Introduced in Senate 
May 22, 2019
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(May 22, 2019)
May 22, 2019
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 1619 (Introduced-in-Senate)


116th CONGRESS
1st Session
S. 1619


To amend the Public Health Service Act to provide for a national campaign to raise awareness of the importance of, and combat misinformation about, vaccines in order to increase vaccination rates.

IN THE SENATE OF THE UNITED STATES

May 22, 2019

Mr. Peters (for himself, Mr. Roberts, and Ms. Duckworth) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Public Health Service Act to provide for a national campaign to raise awareness of the importance of, and combat misinformation about, vaccines in order to increase vaccination rates.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety Act of 2019” or the “VACCINES Act”.

SEC. 2. Improving awareness of disease prevention.

The Public Health Service Act is amended by striking section 313 of such Act (42 U.S.C. 245) and inserting the following:

“SEC. 313. Public awareness campaign on the importance of vaccinations.

“(a) In general.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in coordination with other offices and agencies, as appropriate, shall award competitive grants to one or more public or private entities to carry out a national, evidence-based campaign to increase awareness of vaccines for the prevention and control of diseases, combat misinformation about vaccines, and disseminate scientific and evidence-based, vaccine-related information, with the goal of increasing rates of vaccination across all ages, as applicable, particularly in communities with low rates of vaccination.

“(b) Consultation.—In carrying out the campaign under this section, the Secretary shall consult with appropriate public health and medical experts, including the National Academy of Medicine and medical and public health associations and nonprofit organizations, in the development, implementation, and evaluation of the evidence-based public awareness campaign.

“(c) Requirements.—The campaign under this section—

“(1) shall be a national, evidence-based initiative;

“(2) may include the use of television, radio, the internet, and other telecommunications technologies;

“(3) may be focused to address specific needs of communities with low vaccination rates;

“(4) shall include the development of resources for communities with low vaccination rates, including culturally and linguistically appropriate resources, as applicable;

“(5) shall include the dissemination of vaccine information and communication resources to health care providers and health care facilities, including such providers and facilities that provide prenatal and pediatric care;

“(6) shall be complementary to, and coordinated with, any other Federal efforts and State efforts, as appropriate;

“(7) shall assess the effectiveness of communication strategies to increase vaccination rates; and

“(8) may include the dissemination of scientific and evidence-based vaccine-related information, such as—

“(A) advancements in evidence-based research related to diseases that may be prevented by vaccines and vaccine development;

“(B) information on vaccinations for individuals and communities, including individuals for whom vaccines are not recommended by the Advisory Committee for Immunization Practices, and the effects of low vaccination rates within a community on such individuals;

“(C) information on diseases that may be prevented by vaccines; and

“(D) information on vaccine safety and the systems in place to monitor vaccine safety.

“(d) Evaluation.—The Secretary shall—

“(1) establish benchmarks and metrics to quantitatively measure and evaluate the awareness campaign under this section;

“(2) conduct qualitative assessments regarding the awareness campaign under this section; and

“(3) prepare and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and Committee on Energy and Commerce of the House of Representatives an evaluation of the awareness campaign under this section.

“(e) Authorization of appropriations.—There are authorized to be appropriated to carry out this section and section 317(k) such sums as may be necessary for fiscal years 2020 through 2024.”.

SEC. 3. Grants to address vaccine-preventable diseases.

Section 317(k)(1) of the Public Health Service Act (42 U.S.C. 247b(k)(1)) is amended—

(1) in subparagraph (C), by striking “; and” and inserting a semicolon;

(2) in subparagraph (D), by striking the period and inserting a semicolon; and

(3) by adding at the end the following:

“(E) planning, implementation, and evaluation of activities to address vaccine-preventable diseases, including activities to—

“(i) identify communities at high risk of outbreaks related to vaccine-preventable diseases;

“(ii) pilot innovative approaches to improve vaccination rates in communities with low rates of vaccination;

“(iii) reduce barriers to accessing vaccines and evidence-based information about the health effects of vaccines;

“(iv) partner with community organizations and health care providers to develop and deliver evidence-based interventions to increase vaccination rates; and

“(v) improve delivery of evidence-based vaccine-related information to parents and others; and

“(F) research related to strategies for improving awareness of scientific and evidence-based, vaccine-related information, including for communities with low vaccination rates, in order to understand barriers to vaccination, improve vaccination rates, and assess the public health outcomes of such strategies.”.